Home・Список акций・IQVIA Holdings Inc

IQVIA Holdings Inc

Закрыт

СекторЗдравоохранение

238.6 2.64

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

236.29

Макс.

238.62

Ключевые показатели
By Trading Economics
Доход	-17M 258M
Продажи	217M 4.4B
P/E Средняя по отрасли	28.902 68.51
Прибыль на акцию	2.75
Рентабельность продаж	5.907
Сотрудники	94,000
EBITDA	-18M 790M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+14.5% upside

Дивиденды
By Acuity
Следующий отчет о доходах	27 окт. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	2.7B 38B
Предыдущая цена открытия	235.96
Предыдущая цена закрытия	238.6

Новостные настроения

By Acuity

50%

128 / 340 Рейтинг в Healthcare

IQVIA Holdings Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

8 авг. 2026 г., 00:01 UTC

IQVIA Holdings Inc shares are lower in after-market hours amid broader market concerns over Federal Reserve interest rate policies and a recent weak jobs report.

7 авг. 2026 г., 23:01 UTC

IQVIA Holdings Inc shares are lower in after-market hours, continuing a decline since Friday's close with no specific news identified for the drop.

6 авг. 2026 г., 20:06 UTC

IQVIA Holdings Inc shares are declining today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this movement.

5 авг. 2026 г., 20:03 UTC

Correlated Moves

News

IQVIA Holdings announced a collaboration with Medera to advance cardiac gene therapies. Positive sentiment from this partnership likely supported shares trading higher today.

4 авг. 2026 г., 23:01 UTC

News

IQVIA Holdings Inc announced a collaboration with Medera to enhance cardiac gene therapies. Shares declined during after-market trading, continuing a trend of lower closes.

3 авг. 2026 г., 20:06 UTC

IQVIA Holdings Inc. shares are lower today, breaking a trend of higher closes since Friday. No specific company news was identified to explain the move.

31 июл. 2026 г., 19:16 UTC

News

Shares of IQVIA Holdings lower after first-quarter results.

30 июл. 2026 г., 23:02 UTC

IQVIA Holdings Inc shares are higher in after-market trading, reflecting positive momentum since Thursday's close, despite no specific news driving the movement.

29 июл. 2026 г., 22:06 UTC

Correlated Moves

IQVIA Holdings shares declined in after-hours trading, reflecting broader market unease following the Federal Reserve's decision to maintain interest rates.

28 июл. 2026 г., 20:51 UTC

IQVIA Holdings Inc is trading lower in after-market hours, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

27 июл. 2026 г., 23:12 UTC

IQVIA Holdings Inc. shares are higher in after-market trading, tracking broader gains in European markets, including a rise in the DAX 30 Index.

23 июл. 2026 г., 20:03 UTC

Correlated Moves

IQVIA Holdings Inc shares are higher, supported by a rise in Thermo Fisher Scientific Inc's stock and positive sentiment in the life sciences sector.

22 июл. 2026 г., 16:36 UTC

IQVIA Holdings Inc shares are lower today, continuing a trend of declines. Broader market sentiment is affected by rising crude oil prices and geopolitical tensions.

21 июл. 2026 г., 19:06 UTC

Social Media

Shares of IQVIA Holdings Inc are lower following disappointing first-quarter results. Unusual call options activity exceeding $2 million indicates heightened investor interest.

Сравнение c конкурентами

Изменение цены

IQVIA Holdings Inc Прогноз

Целевая цена

By TipRanks

14.5% рост

Прогноз на 12 месяцев

Средняя 273.31 USD 14.5%

Максимум 300 USD

Минимум 240 USD

Основано на мнении 15 аналитиков Wall Street, спрогнозировавших целевые цены для IQVIA Holdings Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

15 ratings

Покупка

Удержание

Продажа

Основано на мнении 15 аналитиков, присваивавших рейтинги акциям IQVIA Holdings Inc – Данные за последние 3 месяца.

Настроения

By Acuity

128 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.